Clinical Trials Directory

Trials / Conditions / Recurrent Small Cell Lung Carcinoma

Recurrent Small Cell Lung Carcinoma

8 registered clinical trials studyying Recurrent Small Cell Lung Carcinoma.

StatusTrialSponsorPhase
Active Not RecruitingNivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advance
NCT03728361
Dwight OwenPhase 2
CompletedTremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer
NCT02701400
Emory UniversityPhase 2
TerminatedSelinexor in Treating Patients With Relapsed Small Cell Lung Cancer
NCT02351505
Erin BertinoPhase 2
CompletedSirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Ce
NCT01737502
Mayo ClinicPhase 1 / Phase 2
CompletedPegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer
NCT01876446
Roswell Park Cancer InstitutePhase 2
CompletedLinsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer
NCT01533181
National Cancer Institute (NCI)Phase 2
CompletedA Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449
NCT00887159
National Cancer Institute (NCI)Phase 2
CompletedTopotecan Hydrochloride and Doxorubicin Hydrochloride in Treating Relapsed or Refractory Small Cell Lung Cance
NCT00856037
University of NebraskaPhase 1